Screening of liver disease in patients with type 2 diabetes mellitus
Radan Brůha Orcid.org 1
+ Affiliation
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Kwok R, Choi KC, Wong GL et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut 2015. doi: 10.1136/gutjnl-2015-309265. In press.
2. Dvořák K. Možnosti neinvazivní diagnostiky u NAFLS. Gastroent Hepatol 2015; 69 (2): 110–115. doi: 10.14735/amgh2015110.
3. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34 (3): 274–285. doi: 10.1111/j.1365-2036.2011.04724.x.
4. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129 (1): 113–121.
5. Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Dig Dis 2010; 28 (1): 162–168. doi: 10.1159/000 282081.
6. Dvorak K, Hainer R, Petrtyl J et al. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014. doi: 10.5507/bp.2014.033.